Sign Up to like & get
recommendations!
0
Published in 2020 at "Cardiovascular Drugs and Therapy"
DOI: 10.1007/s10557-020-07082-x
Abstract: While low density lipoprotein cholesterol (LDL-C) remains a key contributor of atherosclerotic cardiovascular disease (ASCVD), additional risk factors identified through epidemiological and genetic studies have ushered in a fertile era of drug discovery in lipid-lowering…
read more here.
Keywords:
risk;
biotechnological drugs;
risk factors;
clinical trials ... See more keywords